ValSource Consultant Chris Smalley Appointed to House of Delegates

Compounding Pharmacy Consultant Christopher (Chris) J. Smalley has been appointed to the American Pharmacists Association (APhA) House of Delegates (HOD) as a delegate for the Academy of Pharmaceutical Research and Science. “This role presents authentic opportunities to inform the Association’s policy development process around compounding pharmacy,” Smalley commented. “Through networking and policy-related activities leading up to the House of Delegates meeting, I hear firsthand the new and exciting developments our clients and industry face. I’m able to advocate solutions borne of ValSource’s tailored, risk-based approaches to hospital pharmacies and compounding centers.”

The HOD is the principal policy-making body of the APhA. This democratic forum represents the views and interests of a diverse group of members who meet once a year for two days during the APhA Annual Meeting and Exposition to establish broad policy on health care, medication use and professional and governance matters. In addition, delegates provide input throughout the year on policy topics under consideration by the Association.

Smalley Chris 2010 copyChris Smalley works with pharmacists to design, build and operate compliant compounding facilities. He recently retired from Merck, where he worked for five years on innovative implementation and validation, including Single Use Systems globally. Previously, he was Director of Quality Operations for Wyeth Pharmaceuticals for 12 years with responsibility for setting validation standards and validation activities globally. His research experience includes responsibility for Quality in the U.S. operations of the Sanofi Research Division, and earlier as a plant manger for the Johnson & Johnson family of companies. Chris has been a member of the Parenteral Drug Association (“PDA”) Board of Directors, as well as a member of the PDA Science Advisory Board. Currently, he is a member of the ISPE Disposables CoP. His APhA delegate term runs June 2017 – May 2018.

Reach Chris at